Brooklyn Investment Group’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.55M Buy
11,289
+3,423
+44% +$1.86M 0.17% 85
2025
Q4
$4.6M Buy
7,866
+4,474
+132% +$2.53M 0.21% 78
2025
Q3
$1.38M Sell
3,392
-80
-2% -$37.2K 0.19% 108
2025
Q2
$1.41M Buy
3,472
+1,042
+43% +$436K 0.18% 107
2025
Q1
$1.21M Sell
2,430
-225
-8% -$122K 0.26% 72
2024
Q4
$1.38M Buy
2,655
+148
+6% +$81.4K 0.41% 38
2024
Q3
$1.55M Buy
2,507
+121
+5% +$71.6K 0.51% 34
2024
Q2
$1.38M Hold
2,386
0.59% 35
2024
Q1
$1.38M Sell
2,386
-32
-1% -$18K 0.59% 35
2023
Q4
$1.28M Buy
+2,418
New +$1.17M 0.61% 38

Other funds holding TMO

Brooklyn Investment Group's TMO Position: Q1 2026 in Review

Brooklyn Investment Group increased its Thermo Fisher Scientific (TMO) stake by 44% in Q1 2026, buying an estimated $1.86M and bringing the position to 11,289 shares worth $5.55M. The position accounts for 0.17% of the portfolio, ranked #85.

Brooklyn Investment Group first reported a position in TMO in Q4 2023 and has held it in 10 quarters since. 2,605 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Brooklyn Investment Group held 11,289 shares of Thermo Fisher Scientific worth $5.55M as of Q1 2026.
  • Brooklyn Investment Group bought 3,423 Thermo Fisher Scientific shares in Q1 2026, an estimated $1.86M.
  • Thermo Fisher Scientific made up 0.17% of Brooklyn Investment Group's portfolio in Q1 2026, its #85 holding.
  • Brooklyn Investment Group first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 10 quarters since.
  • 2,605 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.